-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Zymeworks, Raises Price Target to $34

Benzinga·05/08/2026 13:39:53
Listen to the news
Wells Fargo analyst Eva Fortea Verdejo maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $33 to $34.